1. Home
  2. GRCE
  3. GRCE News

Latest GRACE THERAPEUTICS INC (GRCE) News on July 27, 2025

GRCE: NDA Submitted
GRCE

Zacks Small Cap Research

a month ago

GRCE: NDA Submitted

Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104
GRCE

GlobeNewswire

a month ago

Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104

Grace Therapeutics, Inc. (NASDAQ:GRCE) Is Expected To Breakeven In The Near Future
GRCE

Simply Wall St.

a month ago

Grace Therapeutics, Inc. (NASDAQ:GRCE) Is Expected To Breakeven In The Near Future

Grace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business Update
GRCE

GlobeNewswire

a month ago

Grace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business Update

Grace Therapeutics to Participate in the 2025 BIO International Conference
GRCE

GlobeNewswire

a month ago

Grace Therapeutics to Participate in the 2025 BIO International Conference

GRCE: Progress Report
GRCE

Zacks Small Cap Research

2 months ago

GRCE: Progress Report

This Grace Therapeutics Insider Increased Their Holding By 12% Last Year
GRCE

Simply Wall St.

2 months ago

This Grace Therapeutics Insider Increased Their Holding By 12% Last Year

GRCE

MT Newswires

3 months ago

TD Cowen Initiates Coverage on Grace Therapeutics With Buy Rating, $12 Price Target

Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104
GRCE

GlobeNewswire

4 months ago

Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
GRCE

GlobeNewswire

5 months ago

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

Grace Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
GRCE

GlobeNewswire

5 months ago

Grace Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

GRCE

Zacks Small Cap Research

5 months ago

GRCE: STRIVE-ON Results Reported

Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update
GRCE

GlobeNewswire

5 months ago

Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update

Grace Therapeutics secures $15m for GTx-104 pre-commercial development
GRCE

Pharmaceutical Technology

6 months ago

Grace Therapeutics secures $15m for GTx-104 pre-commercial development

GRCE

MT Newswires

6 months ago

Grace Therapeutics Shares Rise After Private Placement Financing of up to $30 Million

Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study
GRCE

Benzinga

6 months ago

Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study

Grace Therapeutics Announces Private Placement Financing of up to $30 Million
GRCE

GlobeNewswire

6 months ago

Grace Therapeutics Announces Private Placement Financing of up to $30 Million

Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
GRCE

GlobeNewswire

6 months ago

Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH

3 US Penny Stocks With Market Cap Under $70M
GRCE

Simply Wall St.

6 months ago

3 US Penny Stocks With Market Cap Under $70M

Grace Therapeutics to Participate in Upcoming Investor Events January 2025
GRCE

GlobeNewswire

7 months ago

Grace Therapeutics to Participate in Upcoming Investor Events January 2025

Grace Therapeutics And 2 Other US Penny Stocks Worth Watching
GRCE

Simply Wall St.

7 months ago

Grace Therapeutics And 2 Other US Penny Stocks Worth Watching

GRCE: aSAH KOL Summary
GRCE

Zacks Small Cap Research

8 months ago

GRCE: aSAH KOL Summary

Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference
GRCE

GlobeNewswire

8 months ago

Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference

GRCE

Zacks Small Cap Research

8 months ago

GRCE: FY:25 Second Quarter Results

Grace Therapeutics And 2 Other US Penny Stocks To Watch
GRCE

Simply Wall St.

8 months ago

Grace Therapeutics And 2 Other US Penny Stocks To Watch

Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update
GRCE

GlobeNewswire

8 months ago

Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update

GRCE: Initiating Coverage – From Confusion to Infusion
GRCE

Zacks Small Cap Research

9 months ago

GRCE: Initiating Coverage – From Confusion to Infusion

Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024
GRCE

GlobeNewswire

9 months ago

Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024

Share on Social Networks: